Showing 671-680 of 5771 results for "".
My Experience Treating Patients with Visually Induced Trigeminal Dysphoria
https://modernod.com/articles/visually-induced-dysphoria-a-potential-leading-source-of-headaches-eyestrain-and-dry-eye-sensation/my-experience-treating-patients-with-visually-induced-trigeminal-dysphoria/37974/A new technology resolves symptoms initially thought to be dry eye disease.GA Case Compendium: Identification of Geographic Atrophy on Color Fundus Photography
https://modernod.com/resources/geographic-atrophy-case-compendium/ga-case-compendium-identification-of-geographic-atrophy-on-color-fundus-photography/56702/Optometry is Changing, Are You Ready to Change Too?
https://modernod.com/topics/business/optometry-is-changing-are-you-ready-to-change-too/37883/Update on Investigational Treatments for Retinal Diseases
https://modernod.com/podcasts/eyewire-news-the-podcast/update-on-investigational-treatments-for-retinal-diseases/39869/Several companies with treatment candidates for retinal diseases provide clinical updates; Nicox releases new phase 3 data for its investigational glaucoma eye drop; the first patient is implanted with Ocumetics’ novel accommodating lens; and ASCRS provides details for its second annual Business ofFDA Issues CRL to Regeneron for Eylea HD Extended Dosing
https://modernod.com/podcasts/eyewire-news-the-podcast/fda-issues-crl-to-regeneron-for-eylea-hd-extended-dosing/37081/The FDA responds to Regeneron’s request to extend dosing intervals for Eylea HD; Regeneron applies for a new indication for Eylea HD; and several recent executive appointments are announced in the ophthalmology industry. Learn more about your ad choices. Visit megaphone.fm/adchoicesAlcon Launches PanOptix Pro in US
https://modernod.com/podcasts/eyewire-news-the-podcast/alcon-launches-panoptix-pro-in-us/37078/Alcon introduces its next-generation trifocal IOL; Alcon announces a deal to advance its clinical-stage allogeneic cell therapy; and Bausch + Lomb announces a voluntary recall of IOLs on its enVista platform. Learn more about your ad choices. Visit megaphone.fm/adchoices89. Five Years Deep: Optometry Happy Hour Edition
https://modernod.com/podcasts/four-eyes/89-five-years-deep-optometry-happy-hour-edition/37039/In honor of the podcast’s fifth year anniversary, Deepon and Amrit host another popular Happy Hour episode and play an Optometry version of “Have You Ever”. So grab your drink, sit back, and listen as our two hosts go down memory lane of their most wild patient experiences!The Four Eyes Podcast is bFDA Expands Product Label for Iluvien
https://modernod.com/podcasts/eyewire-news-the-podcast/fda-expands-product-label-for-iluvien/37076/Iluvien receives a major label expansion; Bausch and Lomb launches a new orthokeratology lens fitting system; and several updates are announced in development wet AMD candidates. Learn more about your ad choices. Visit megaphone.fm/adchoicesFDA Approves Genentech's Susvimo Ocular Implant for DME
https://modernod.com/podcasts/eyewire-news-the-podcast/fda-approves-genentechs-susvimo-ocular-implant-for-dme/37070/The FDA approves a label expansion for Genentech’s Susvimo implant; Iantrek completes the first commercial cases of its C.Rex micro-interventional system; and there are several executive leadership announcements made in ophthalmology. Learn more about your ad choices. Visit megaphone.fm/adchoicesZeiss MEL 90 Approved by FDA
https://modernod.com/podcasts/eyewire-news-the-podcast/zeiss-mel-90-approved-by-fda/37068/Zeiss receives a major approval for its new excimer laser; Bausch + Lomb makes two deals to bolster its pipeline in glaucoma and geographic atrophy; and Rayner announces the full European launch of its RayOne Galaxy IOLs. Learn more about your ad choices. Visit megaphone.fm/adchoices